FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096117 [Registered on: 15/10/2025] Trial Registered Prospectively
Last Modified On: 15/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [feeding pattern]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to compare the difference in growth and body composition status at discharge in very preterm babies who were given early exclusive enteral nutrition with babies who were given conventional nutrition 
Scientific Title of Study   A Randomized Controlled Trial of Early Exclusive Enteral Nutrition vs. Conventional Nutrition in 28-31 + 6 Weeks of Gestation Preterm Neonates and Its Effects on Growth and Body Composition at Discharge 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Viswanadhula S L V Bhargav 
Designation  Senior Resident 
Affiliation  Postgraduate Institute of Medical Education and Research, Chandigarh 
Address  Neonatal unit, Block C, Level 3, Nehru Hospital, PGIMER, Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  7013493522  
Fax    
Email  bhargavviswanadhula@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kanya Mukhopadhyay 
Designation  Professor 
Affiliation  Postgraduate Institute of Medical Education and Research, Chandigarh 
Address  Neonatal unit, Block C, Level 3, Nehru Hospital, PGIMER, Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  7013493522  
Fax  0172-2744401  
Email  kanyapgi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kanya Mukhopadhyay 
Designation  Professor 
Affiliation  Postgraduate Institute of Medical Education and Research, Chandigarh 
Address  Neonatal unit, Block C, Level 3, Nehru Hospital, PGIMER, Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  7013493522  
Fax  0172-2744401  
Email  kanyapgi@gmail.com  
 
Source of Monetary or Material Support  
Postgraduate Institute of Medical Education and Research, Chandigarh,India PINCODE:160012 
 
Primary Sponsor  
Name  Dr Viswanadhula S L V Bhargav 
Address  Neonatal Unit, Level 3, Block C, Nehru Hospital, PGIMER, Chandigarh India PINCODE: 160012 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Viswanadhula S L V Bhargav  PGIMER ,Chandigarh  Neonatal unit, Block C, Level 3, Nehru Hospital, Chandigarh
Chandigarh
CHANDIGARH 
07013493522

bhargavviswanadhula@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Postgraduate Institute of Medical Education and Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: P84||Other problems with newborn,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional nutrition in which I.V. fluids and parenteral nutrition started on day 1, and enteral feeds were initiated on day 1 and gradually increased (20-30 ml per kg per day) depending on tolerance. (as per current unit protocol)   either mother milk or donor human milk will be used 
Intervention  Early exclusive enteral nutrition from day 1 of life if abdominal examination is normal.   either mother milk or donor human milk will be given Intervention will be started within 2 hours of life and will be continued as long as baby tolerates feeds 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  30.00 Day(s)
Gender  Both 
Details  28+0-31+6 weeks GA gestation neonates, whose abdominal examination is normal and ready to be initiated on feeds and admitted to the neonatal unit  
 
ExclusionCriteria 
Details  Major Congenital malformation and syndromic babies
Surgical conditions of the abdomen where feeding can’t be initiated
Absent or Reverse end-diastolic flow (AEDForREDF)
Severe perinatal asphyxia
Refusal of donor human milk
Hemodynamic instability within 2 hours of birth
Less than 1 kg at birth
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1)Proportion of EUGR in 2 groups
2)Body composition at discharge or at 37-40 week PMA
 
there is no specific time point to assess the outcome. It is done at discharge.Discharge can be done at 34-37 weeks PMA to preterm babies usually 
 
Secondary Outcome  
Outcome  TimePoints 
Anthropometry in both groups at time of discharge - weight, length, head circumference  in this study anthropometry will be taken at the time of discharge. there is no specific timepoint for discharge. so we cant determine a specific timepoint 
Anthropometry (weight, length, head circumference in both groups as per AGA & SGA subgroups at the time of discharge
 
in this study anthropometry will be taken at the time of discharge. there is no specific timepoint for discharge. so we cant determine a specific timepoin 
Time taken to achieve full feeds in 2 groups (150 ml per kg per day)
 
It is the duration by which baby will be accepting full feeds. There is no specific time point 
Incidence of culture-positive sepsis in both groups
 
 
Incidence of feed intolerance and NEC grade 2 and above during hospital stay
 
 
All-cause mortality    
Length of hospital stay   
Incidence of BPD, Anemia, NEC, Osteopenia of prematurity
 
 
Number of babies required TPN during hospital stay
 
 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

We shall be screening all very preterm babies (28-31+6 weeks gestation) born in PGIMER and admitted consecutively in the neonatal unit of PGIMER, and will be enrolled after meeting the inclusion and exclusion criteria, within 2 hours of birth. Parental or guardian written consent will be obtained after explaining the need for the study and a written PIS will be provided in local languages. For the calculation of gestational age, it will be assigned as per LMP, and postnatally will be confirmed by using New Ballard scoring. By using Intergrowth-21 at birth charts, we will allocate the newborn as SGA or AGA and SES will be assessed by the Modified Kuppuswamy SES scale.

Randomization process: On day 1 of life, at 2 hours of life, neonates will be randomized to receive either early exclusive enteral nutrition (group A) or they will be initiated on conventional nutrition (group B) based on eligibility. Random numbers will be computer-generated and placed in sealed, opaque envelopes, and a non-PI person will generate these numbers. As this is an open trial, the PI could not be blinded. There will be 2 subgroups, decided a priori, consisting of an 80% sample size in the AGA group and 20% in the SGA group.

Mothers and newborns will have their demographic and clinical information documented. Birth anthropometry (weight, length, and head circumference) and a thorough clinical examination will also be performed as per the procedure described below.

Type of milk to be used: Mother’s own milk (MOM) will be the preferred feed; however, if MOM is not available, pasteurized donor human milk (DHM) will be used till full volume EBM is not available or for a minimum of 2 weeks, whichever is earlier.

Babies enrolled in both groups will be given feeds or fluids as per the institutional protocol as described. Time to attain full enteral feeds (150 ml per kg per day and sustaining it for more than 24 hours) will be noted. The number of episodes of feed intolerance during hospital stay is noted in each patient. The feed intolerance will be defined as the presence of any two of these criteria: gastric residuals more than 33% of total feeds on 2 consecutive occasions (if total feed volume more than 8 ml) or greater than 50% on a single occasion (if total feed volume was less than 8 ml), abdominal distension (increase in abdominal girth by more than 2 cm from baseline), brown, bilious, or blood stained gastric aspirates, vomiting for which feeds were withheld for more than 12 hours, and absent bowel sounds on auscultation in two different quadrants for two minutes.

Incidence of sepsis and number of antibiotic days in both groups is compared. All-cause mortality is compared in both groups. If any baby later on develops a surgical abdomen or is not being given significant feeds for more than 5 days due to any cause, they will be excluded from the final comparison. Number of babies being given Total Parenteral Nutrition (TPN) (clinician’s judgement) in the hospital course in both groups will also be noted. Babies in both groups will be given feed fortification as per institute protocol (if inadequate weight gain despite feed volume of 180-200 ml per kg per day), Kangaroo Mother Care (KMC), and supplements will be started as per protocol in babies in both groups. Weekly anthropometry will be collected and noted. Babies will be monitored for Osteopenia of Prematurity (OOP) and anemia as per protocol during the hospital stay. Babies will be assessed for fitness to discharge (clinician’s judgement), and before discharge, growth and body composition will be assessed using bioelectrical impedance analysis.

WEIGHT - It will be recorded on an electronic weighing scale with an accuracy of 5 grams, with the neonate in nude or minimal light clothing, and the child will be placed in the middle of the weighing pan.
LENGTH - Child will be placed in supine position on an infantometer. The head will be held firmly by one person. Legs will be straightened, keeping feet at right angles to legs with toes pointing upward. The free footboard will be brought into firm contact with the child’s heels. The accuracy should be 0.5 cm.
HEAD CIRCUMFERENCE - Using non-stretchable tape, the maximum circumference of the head from the occipital protuberance to the supraorbital ridges will be recorded. The accuracy should be 0.1 cm.

All these parameters will be recorded weekly and at discharge. All the above anthropometric measurements will be plotted in the Intergrowth chart, and centiles will be calculated.

BODY COMPOSITION: Maltron Bioscan Touch i8-Nano will be used to measure neonatal body composition.

 
Close